Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1)

Autor: Mohamed Abbas, Alison Holmes, Claire Kilpatrick, Maria Virginia Villegas, JULIE STORR, Petra Gastmeier, Karl-Heinz Krause, Enrique Castro-Sánchez, Raheelah Ahmad, Marc Mendelson, Sara Tomczyk, Carolyn Tarrant
Přispěvatelé: NIHR knowledge mobilisation fellowship, 2017 Geneva IPC-Think Tank, Andremont, A., Bell, M., Borg, M., Carmeli, Y., Conly, J., Eggimann, P., Gastmeier, P., Grayson, L., Harbarth, S., Hernandez, M., Herwaldt, L., Holmes, A., Jernigan, J.A., Kolwaite, A., Krause, K.H., Larson, E., Masson-Roy, S., Mehtar, S., Mendelson, M., Lin, L.M., Moldovan, A., Monnet, D., Ndoye, B., Nthumba, P., Ogunsola, F., Park, B., Perencevich, E., Samore, M., Seto, W.H., Srinivasan, A., Tacconelli, E., Talaat, M., Villegas, M.V., Voss, A., Walsh, T., Widmer, A., Abbas, Mohamed, Conly, John, Eggimann, Philippe, Harbarth, Stéphan Juergen, Krause, Karl-Heinz, Moldovan, Andréea Anamaria, Monnet, Dominique Ndiouga, Ndoye, Babacar, Widmer, Andréas
Rok vydání: 2019
Předmět:
0301 basic medicine
Biomedical Research
Antimicrobial Stewardship
WHO
CDC
Change
ECDC
Implementation
Infection prevention and control
Institutional
International
National
0302 clinical medicine
RA0421
Health care
Infection control
Antimicrobial stewardship
Medicine
Pharmacology (medical)
030212 general & internal medicine
ddc:616
Cross Infection
Anti-Bacterial Agents
Infectious Diseases
Patient Safety
Microbiology (medical)
Healthcare associated infections
030106 microbiology
Translational research
World Health Organization
lcsh:Infectious and parasitic diseases
03 medical and health sciences
Patient safety
Drug Resistance
Bacterial

Humans
lcsh:RC109-216
Curriculum
Infection Control
Medical education
business.industry
Research
Health Plan Implementation
Public Health
Environmental and Occupational Health

United States
Group Processes
Implementation research
Centers for Disease Control and Prevention
U.S

business
Zdroj: Antimicrobial resistance and infection control, vol. 8, pp. 87
Antimicrobial Resistance and Infection Control, Vol. 8, No 87 (2019)
Antimicrobial Resistance and Infection Control, Vol 8, Iss 1, Pp 1-9 (2019)
Antimicrobial Resistance and Infection Control
ISSN: 2047-2994
Popis: Background\ud Around 5–15% of all hospital patients worldwide suffer from healthcare-associated infections (HAIs), and years of excessive antimicrobial use in human and animal medicine have created emerging antimicrobial resistance (AMR). A considerable amount of evidence-based measures have been published to address these challenges, but the largest challenge seems to be their implementation.\ud \ud Methods\ud In June 2017, a total of 42 experts convened at the Geneva IPC-Think Tank to discuss four domains in implementation science: 1) teaching implementation skills; 2) fostering implementation of IPC and antimicrobial stewardship (AMS) by policy making; 3) national/international actions to foster implementation skills; and 4) translational research bridging social sciences and clinical research in infection prevention and control (IPC) and AMR.\ud \ud Results\ud Although neglected in the past, implementation skills have become a priority in IPC and AMS. They should now be part of any curriculum in health care, and IPC career paths should be created. Guidelines and policies should be aligned with each other and evidence-based, each document providing a section on implementing elements of IPC and AMS in patient care. International organisations should be advocates for IPC and AMS, framing them as patient safety issues and emphasizing the importance of implementation skills. Healthcare authorities at the national level should adopt a similar approach and provide legal frameworks, guidelines, and resources to allow better implementation of patient safety measures in IPC and AMS. Rather than repeating effectiveness studies in every setting, we should invest in methods to improve the implementation of evidence-based measures in different healthcare contexts. For this, we need to encourage and financially support collaborations between social sciences and clinical IPC research.\ud \ud Conclusions\ud Experts of the 2017 Geneva Think Tank on IPC and AMS, CDC, and WHO agreed that sustained efforts on implementation of IPC and AMS strategies are required at international, country, and hospital management levels, to provide an adequate multimodal framework that addresses (not exclusively) leadership, resources, education and training for implementing IPC and AMS. Future strategies can build on this agreement to make strategies on IPC and AMS more effective.
Databáze: OpenAIRE